I

INmune Bio
D

INMB

1.44700
USD
0.11
(7.99%)
مغلق
حجم التداول
6,591
الربح لكل سهم
-1
العائد الربحي
-
P/E
-1
حجم السوق
38,468,868
أصول ذات صلة المقالات
المزيد

العنوان: INmune Bio

القطاع: Healthcare
الصناعة: Biotechnology
INmune Bio Inc is a clinical stage biotechnology pharmaceutical company focused on developing and commercializing its product candidates to treat diseases where inflammation and immunology cause a dysfunctional immune system contributing to disease. The company's pipeline products include INKmune, XPro1595, and others. It has three product platforms; The CORDStrom product platform, The DN-TNF product platform, and The Natural Killer Cell Priming Platform.